IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IRADIMED CORPORATION on July 30, 2015. The filing serves to announce the Company's financial results for the second quarter ended June 30, 2015, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are referenced as being contained within the attached press release (Exhibit 99.1), which is not included in the source text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the issuance of results for the second quarter of 2015.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risks, contingencies, or unusual items. The document explicitly states that the information in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) to obtain specific Q2 2015 financial figures.
- Verify year-over-year and quarter-over-quarter performance metrics not present in this summary.
- Check for any forward-looking statements or guidance included in the press release.
- Confirm the status of the Company's liquidity and debt obligations as detailed in the full earnings release.